Novo Nordisk to Seek Approval for Pill to Treat Diabetes in Young Patients

2 days ago 3
A late-stage proceedings showed that oral semaglutide importantly reduced humor sweetener successful 10- to 17-year-olds.
Read Entire Article
  1. Homepage
  2. Health
  3. Novo Nordisk to Seek Approval for Pill to Treat Diabetes in Young Patients

Related

The viral manifesto of 'anti-woke' tech boss with NHS and defence contracts

The viral manifesto of 'anti-woke' tech boss with NHS and de...

11 hours ago 3
Injectable peptides are worrying doctors, a popular heart procedure has risky tradeoffs, and AI could benefit dementia patients. Read more in this week’s WSJ Health newsletter:

Injectable peptides are worrying doctors, a popular heart pr...

20 hours ago 4
WSJ readers weigh in on America’s great inventions. Don’t forget the dishwasher!

WSJ readers weigh in on America’s great inventions. Don’t fo...

21 hours ago 2

Popular

7 New Songs You Should Hear Now

7 New Songs You Should Hear Now

3 days ago 27
Vance’s Trip to Islamabad on Hold as U.S. Says Iran Failed to Respond to Its Terms

Vance’s Trip to Islamabad on Hold as U.S. Says Iran Failed t...

3 days ago 27
Pentagon to Stop Requiring Members of Military to Get Flu Vaccines

Pentagon to Stop Requiring Members of Military to Get Flu Va...

3 days ago 19
Areas getting 'beaver ready' for possible release

Areas getting 'beaver ready' for possible release

3 days ago 17
In Trump’s Orbit, Women Aren’t the Only Ones Concerned About Their Looks

In Trump’s Orbit, Women Aren’t the Only Ones Concerned About...

6 days ago 14
About Us · Contact Us · Privacy Policy ·

© DISQUS CLUB 2026. All rights are reserved